|
Name |
Acaciicolinol F
|
Molecular Formula | C15H24O3 | |
IUPAC Name* |
(2S,3S,6S)-9-(hydroxymethyl)-5,5-dimethyl-1-methylidenespiro[5.5]undec-9-ene-2,3-diol
|
|
SMILES |
CC1(C[C@@H]([C@H](C(=C)[C@]12CCC(=CC2)CO)O)O)C
|
|
InChI |
InChI=1S/C15H24O3/c1-10-13(18)12(17)8-14(2,3)15(10)6-4-11(9-16)5-7-15/h4,12-13,16-18H,1,5-9H2,2-3H3/t12-,13-,15-/m0/s1
|
|
InChIKey |
HLOIDCWKBJKBMD-YDHLFZDLSA-N
|
|
Synonyms |
Acaciicolinol F
|
|
CAS | NA | |
PubChem CID | 139590765 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 252.35 | ALogp: | 1.0 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 60.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.628 |
Caco-2 Permeability: | -4.556 | MDCK Permeability: | 0.00000965 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.989 |
30% Bioavailability (F30%): | 0.989 |
Blood-Brain-Barrier Penetration (BBB): | 0.128 | Plasma Protein Binding (PPB): | 47.37% |
Volume Distribution (VD): | 0.952 | Fu: | 68.03% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.197 |
CYP2C19-inhibitor: | 0.015 | CYP2C19-substrate: | 0.714 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.184 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.095 |
CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.147 |
Clearance (CL): | 6.525 | Half-life (T1/2): | 0.354 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.322 |
Drug-inuced Liver Injury (DILI): | 0.047 | AMES Toxicity: | 0.042 |
Rat Oral Acute Toxicity: | 0.576 | Maximum Recommended Daily Dose: | 0.695 |
Skin Sensitization: | 0.044 | Carcinogencity: | 0.927 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.187 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003904 | 0.684 | D04VIS | 0.275 | ||||
ENC003903 | 0.655 | D0D1SG | 0.266 | ||||
ENC003906 | 0.574 | D0KR5B | 0.266 | ||||
ENC003911 | 0.477 | D0V9DZ | 0.247 | ||||
ENC003909 | 0.455 | D08PIQ | 0.247 | ||||
ENC003913 | 0.441 | D0R7JT | 0.247 | ||||
ENC005118 | 0.412 | D03BLF | 0.242 | ||||
ENC003912 | 0.391 | D0S0NK | 0.235 | ||||
ENC003907 | 0.391 | D0CW1P | 0.230 | ||||
ENC003908 | 0.391 | D07DVK | 0.230 |